Linda Gammage, MSW, LCSW, passed away on December 26, 2018.
The court ruled that the entirety of the ACA is unconstitutional because the 2017 tax reform law eliminated the individual mandate tax penalty.
Sangamo announced it has treated the first patient in a Phase 1/2 clinical trial evaluating SB-FIX, the company’s investigational gene therapy for patients with hemophilia B.
Seven ways your gift to NHF will support people with bleeding disorders.
The data presented was from 33 patients who have completed five years of treatment with Jivi®.
The data from both studies confirmed the safety and sustained efficacy of Eloctate ® and Alprolix ® over four years of treatment.
NHF's research grants support a variety of disciplines and levels of expertise.
The two recommendations address gene therapy clinical trials, and use of emicizumab-kxwh.
This chapter includes new product approvals and Guelcher explains that ITI could be the solution to eradicate the inhibitor itself.
Each year, hundreds of new parents hear the words, “Your child has a bleeding disorder.” This can be frightening to parents, especially if there is no previous family history of the disorder.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car